推荐产品
一般說明
β 淀粉样蛋白 1-42是整合膜结合淀粉样前体蛋白的衍生物。它是阿尔茨海默′病肽的最重要形式。
應用
β 淀粉样蛋白 1-42, aβ, 超纯, HFIP, 重组人已用于：
- 通过膜片钳（patch-clamp）技术研究其对人星形细胞瘤细胞中线粒体BKCa（mitoBKCa）活性的影响
- 研究其对小鼠成神经细胞瘤细胞中营养不良性神经突（DN）形成蛋白的蛋白质水平变化的影响
- 诱发实验研究用大鼠模型的阿尔茨海默病
生化／生理作用
β 淀粉样蛋白1-42 导致神经毒性，并与阿尔茨海默病的发病机制有关。 β 淀粉样蛋白（βA） 可作为许多受体和其它分子的配体，参与组织和血脑屏障中的复杂运输途径（trafficking pathway）。β它和淀粉不溶素一起提高环磷酸腺苷（cAMP）和 Ca2+水平，继而激活多个信号通路介导子，如丝裂原激活蛋白激酶（MAPK）、 蛋白激酶A/B和 cFOS。它也是AD相关神经炎症的主要来源。
法律資訊
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
13 - Non Combustible Solids
水污染物質分類（WGK）
WGK 1
閃點（°F）
Not applicable
閃點（°C）
Not applicable
其他客户在看
Annika Olsson et al.
Clinical chemistry, 51(2), 336-345 (2004-11-26)
To simultaneously study several biomarkers for Alzheimer disease (AD), we used the xMAP technology to develop and evaluate a multiparametric bead-based assay for quantification of beta-amyloid((1-42)) [Abeta((1-42))], total tau (T-TAU), and hyperphosphorylated tau [P-TAU((181P))] in cerebrospinal fluid (CSF). We compared
Stephanie J Soscia et al.
PloS one, 5(3), e9505-e9505 (2010-03-09)
The amyloid beta-protein (Abeta) is believed to be the key mediator of Alzheimer's disease (AD) pathology. Abeta is most often characterized as an incidental catabolic byproduct that lacks a normal physiological role. However, Abeta has been shown to be a
Mohabbat Ahmadi et al.
Avicenna journal of phytomedicine, 9(5), 465-473 (2019-09-14)
Zataria multiflora (ZM) is a plant with ethnopharmacological value which was recently tested to reduce symptoms of Alzheimer's disease (AD). The aim of the present study was to determine the effect of ZM essential oil on spatial cognitive and noncognitive
Ye Ji Lee et al.
Frontiers in molecular neuroscience, 16, 1150399-1150399 (2023-05-05)
Growth-associated protein 43 (GAP-43) is known as a neuronal plasticity protein because it is widely expressed at high levels in neuronal growth cones during axonal regeneration. GAP-43 expressed in mature adult neurons is functionally important for the neuronal communication of
Akiko Amano et al.
Journal of nanobiotechnology, 21(1), 36-36 (2023-02-02)
Although a large amount of evidence has revealed that amyloid β (Aβ), especially Aβ oligomers, protofibrils, and pyroglutamated Aβs, participate primarily in the pathophysiological processes of Alzheimer's disease, most clinical trials of anti-Aβ antibody therapy have never acquired successful efficacy
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门